April 29, 2020 / 9:21 PM / a month ago

BRIEF-Apellis Pharmaceuticals Reports First Quarter 2020 Financial Results

April 29 (Reuters) - Apellis Pharmaceuticals Inc:

* APELLIS PHARMACEUTICALS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS

* APELLIS PHARMACEUTICALS - FULL ENROLLMENT OF TWO PHASE 3 TRIALS IN GEOGRAPHIC ATROPHY EXPECTED IN Q2 OF 2020

* APELLIS PHARMACEUTICALS - QTRLY LOSS PER SHARE $2.29 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below